Healthcare -
Biotechnology - NASDAQ - US
$ 4.1375
-0.541 %
$ 86.1 M
Market Cap
-0.7
P/E
ADVM - DEPRECIATION & AMORTIZATION
Depreciation & Amortization ADVM - Adverum Biotechnologies, Inc.
5.64 M
LAST VALUE
10.23%
2 YEAR CAGR
26.39%
5 YEAR CAGR
71.26%
10 YEAR CAGR